We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
-2.47%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$1.29B
AUM Growth
+$68.2M
Cap. Flow
+$187M
Cap. Flow %
14.53%
Top 10 Hldgs %
5.34%
Holding
1,517
New
416
Increased
314
Reduced
381
Closed
383

Top Buys

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$8.63M
2
DDOG icon
Datadog
DDOG
+$8.06M
3
SMTC icon
Semtech
SMTC
+$7.84M
4
EW icon
Edwards Lifesciences
EW
+$7.74M
5
MMM icon
3M
MMM
+$7.53M

Top Sells

Rank Stock Value
1
GFS icon
GlobalFoundries
GFS
+$7.26M
2
ASAN icon
Asana
ASAN
+$7.08M
3
ADM icon
Archer Daniels Midland
ADM
+$6.58M
4
DIS icon
Walt Disney
DIS
+$6.4M
5
EBAY icon
eBay
EBAY
+$6.35M

Sector Composition

Rank Sector Weight
1 Technology 22.24%
2 Healthcare 15.76%
3 Financials 14.23%
4 Industrials 13.95%
5 Consumer Discretionary 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARC
1126
DELISTED
ARC Document Solutions, Inc.
ARC
$23K ﹤0.01%
10,262
-621
-6% -$1.73K
NOVN
1127
DELISTED
Novan, Inc. Common Stock
NOVN
$21K ﹤0.01%
11,068
– –
ASMB icon
1128
Assembly Biosciences
ASMB
$503M
$20K ﹤0.01%
+1,037
New +$25.1K
AWH
1129
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$19K ﹤0.01%
3,466
-46
-1% -$495
CTMX icon
1130
CytomX Therapeutics
CTMX
$690M
$16K ﹤0.01%
10,808
– –
VATE icon
1131
INNOVATE Corp
VATE
$99.6M
$15K ﹤0.01%
2,122
– –
SRAX
1132
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$12K ﹤0.01%
65,537
-15,846
-19% -$37.1K
RUBY
1133
DELISTED
Rubius Therapeutics, Inc
RUBY
$9K ﹤0.01%
19,975
-924
-4% -$693
AA icon
1134
Alcoa
AA
$12.4B
– –
-7,650
Closed -$349K
AAON icon
1135
Aaon
AAON
$7.58B
– –
-17,481
Closed -$638K
ABM icon
1136
ABM Industries
ABM
$2.86B
– –
-27,058
Closed -$1.18M
ABT icon
1137
Abbott
ABT
$185B
– –
-21,192
Closed -$2.3M
ACI icon
1138
Albertsons Companies
ACI
$5.58B
– –
-98,889
Closed -$2.64M
ACM icon
1139
Aecom
ACM
$9.61B
– –
-28,643
Closed -$1.87M
ACRS icon
1140
Aclaris Therapeutics
ACRS
$772M
– –
-11,799
Closed -$165K
ACT icon
1141
Enact Holdings
ACT
$6.68B
– –
-71,026
Closed -$1.53M
ACVA icon
1142
ACV Auctions
ACVA
$1.4B
– –
-52,370
Closed -$342K
ADEA icon
1143
Adeia
ADEA
$3.07B
– –
-160,215
Closed -$612K
ADI icon
1144
Analog Devices
ADI
$185B
– –
-15,490
Closed -$2.26M
ADPT icon
1145
Adaptive Biotechnologies
ADPT
$3.68B
– –
-32,530
Closed -$263K
ADTN icon
1146
Adtran
ADTN
$718M
– –
-37,479
Closed -$657K
AEHR icon
1147
Aehr Test Systems
AEHR
$3.58B
– –
-16,522
Closed -$124K
AEP icon
1148
American Electric Power
AEP
$69.9B
– –
-19,724
Closed -$1.89M
AGEN
1149
Agenus
AGEN
$346M
– –
-2,811
Closed -$107K
AGS
1150
DELISTED
PlayAGS
AGS
– –
-22,645
Closed -$117K
44 45
46
47 48

Similar funds

RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
LOAME
Lombard Odier Asset Management (Europe) London, United Kingdom $1.85B AUM 27.05% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Occudo Quantitative Strategies's Q3 2022 Portfolio in Review

As of Q3 2022, Occudo Quantitative Strategies held 1,517 positions worth $1.29B, up 5.6% from $1.22B the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Occudo Quantitative Strategies deployed $187M of net new capital in Q3 2022, opening 416 new positions and adding to 314 existing holdings. Its largest new stake was Spotify: 80,608 shares worth $6.96M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was GlobalFoundries, an estimated $7.26M trimmed.

  • Occudo Quantitative Strategies's largest Q3 2022 buy was Spotify: 80,608 shares worth $6.96M.
  • Occudo Quantitative Strategies added most to Edwards Lifesciences in Q3 2022, an estimated $7.74M increase.
  • Occudo Quantitative Strategies's biggest Q3 2022 reduction was GlobalFoundries, cutting an estimated $7.26M.
  • Occudo Quantitative Strategies fully exited Walt Disney in Q3 2022, selling an estimated $6.4M.
  • Occudo Quantitative Strategies's ten largest holdings make up 5.3% of its $1.29B portfolio in Q3 2022.
  • Occudo Quantitative Strategies opened 416 new positions and closed 383 in Q3 2022.
  • Occudo Quantitative Strategies's portfolio value rose 5.6% quarter-over-quarter to $1.29B.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.